E-mail a Wiley Online Library Link

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials Clinical & Experimental Allergy 42

Version of Record online: 20 APR 2012 | DOI: 10.1111/j.1365-2222.2012.03991.x

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field